1-3 of 3
Hannah Cherniawsky, BSc, MD
Close
Sort by
Journal Articles

Treatment of Myeloma Patients Progressing on Lenalidomide-Based Maintenance after ASCT Performed As Part of 1 st , 2 nd or 3 rd Line Therapy: Real-World Results from the National Myeloma Canada Research Network (MCRN) Database

Donna E Reece, MD, Esther Masih-Khan, PhD, Eshetu G Atenafu, MSc, P.Stat, Victor Jimenez-Zepeda, MD, Arleigh McCurdy, MD, Kevin Song, MD, Richard Leblanc, MDFRCPC, Michael Sebag, MD PhD, Darrell J White, MD, Hannah Cherniawsky, BSc,MD, Tony Reiman, MD, Julie Stakiw, MD, Martha L Louzada, MDMSc, Rami Kotb, MD, Muhammad Aslam, MD, Engin Gul, BS, MBA, Christopher P Venner, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3173.
https://doi.org/10.1182/blood-2019-125810
Published: 2019
Journal Articles

Lenalidomide Maintenance Does Not Negatively Impact Overall and Progression Free Survival Using Lenalidomide-Based Regimens for Multiple Myeloma in First Relapse

Hannah Cherniawsky, BSc,MD, Zack M. Breckenridge, BSc, Irwindeep Sandhu, MD FRCPC, Michael P. Chu, MD, Joanne D. Hewitt, NP, PhD, Ismail Ismail, Andrew R Belch, MD, Linda M. Pilarski, PhD, Tatiana Nikitina, Christopher P. Venner, MD FRCPC
Journal: Blood
Blood (2018) 132 (Supplement 1): 5643.
https://doi.org/10.1182/blood-2018-99-117705
Published: 2018
Journal Articles

The Survival Impact of Lenalidomide Maintenance Chemotherapy in Multiple Myeloma Patients Treated with Autologous Stem Cell Transplant and Bortezomib-Based Induction: An Analysis of Real World Data

Hannah Cherniawsky, BSc, MD, Irwindeep Sandhu, MDFRCPC, Michael P. Chu, MD, Joanne D. Hewitt, NP, PhD, Ismail Ismail, Andrew Belch, Linda M. Pilarski, PhD, Tatiana Nikitina, PhD, Christopher P. Venner, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3132.
https://doi.org/10.1182/blood.V130.Suppl_1.3132.3132
Published: 2017